To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TOP2ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
351 supporting clones for gene TOP2A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA963278 stomach .a -8 to 541 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA511369 brain .a 1 to 552 10 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB136989 thymus .a 1 to 542 10 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA456570 tongue, tumor tissue .a 1 to 556 9 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA757911   .a 1 to 263 9 to 271   capped   270/272
(99 %)
4 diff
(98.6 %id)
DA759633   .a 1 to 244 9 to 252   capped   251/251
(100 %)
0 diff
(100 %id)
DA798972 brain .a 1 to 249 9 to 257   capped   256/256
(100 %)
0 diff
(100 %id)
DA805186 brain .a 1 to 650 9 to 658   tiling clone, capped   657/657
(100 %)
0 diff
(100 %id)
DB065712 testis .a 1 to 551 9 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB086044 testis .a 1 to 547 9 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DB070265 testis .a 1 to 538 3 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB072527 testis .a 1 to 554 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
EC556739 Prostate .a 21 to 125 105 to 1       105/105
(100 %)
0 diff
(100 %id)
CN336142 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 53 to 617 1 to 565       565/565
(100 %)
0 diff
(100 %id)
BC140791 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 54 to 5446 1 to 5391 exact tiling clone,   5391/5391
(100 %)
1 diff
(100.0 %id)
TI_1968230471   .a 54 to 1046 92 to 1079       985/1163
(84 %)
36 diff
(97.0 %id)
TI_1968235883   .a 54 to 562 88 to 596       509/600
(84 %)
13 diff
(97.9 %id)
TI_1968236057   .a 54 to 661 282 to 886     Submitted on the opposite strand 605/1059
(57 %)
11 diff
(99.0 %id)
J04088   .a 65 to 4838 19 to 4792 S1295P     4774/4792
(99 %)
7 diff
(99.9 %id)
AF285159   .a 83 to 1582 1 to 1743       1521/1743
(87 %)
13 diff
(99.3 %id)
DB068858 testis .a 88 to 639 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CN336164 embryonic stem cells, DMSO-treated H9 cellline .a 104 to 686 131 to 713       705/713
(98 %)
6 diff
(99.2 %id)
DW425919 Liver .a 104 to 199 164 to 257       244/284
(85 %)
16 diff
(94.4 %id)
DW434748 Liver .a 104 to 130 180 to 206   AAA   189/206
(91 %)
6 diff
(97.1 %id)
DW435057 Liver .a 104 to 130 180 to 206   AAA   189/206
(91 %)
6 diff
(97.1 %id)
DA504676 brain .a 104 to 524 127 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA506579 brain .a 104 to 547 128 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BC013429 Lung, mucoepidermoid carcinoma .a 104 to 3002 148 to 3046   available from MGC, AAA   3046/3046
(100 %)
1 diff
(100.0 %id)
BF132893 lung, mucoepidermoid carcinoma .a 104 to 558 129 to 586   available from MGC,   586/880
(66 %)
13 diff
(98.6 %id)
BC062677 Pooled, 40 cell lines .a 104 to 161 146 to 203   available from MGC,   199/221
(90 %)
4 diff
(98.2 %id)
BP281983 bone marrow .a 104 to 560 136 to 592       592/592
(100 %)
0 diff
(100 %id)
DA652433   .a 104 to 555 129 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
NM_001067.3   .a 104 to 5676 181 to 5753 exact RefSeq,   5753/5753
(100 %)
0 diff
(100 %id)
DA757211   .a 104 to 533 127 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA804806 brain .a 104 to 530 127 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA808213 brain .a 104 to 539 133 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA810503 brain .a 104 to 516 127 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BP315271 mammary gland .a 104 to 559 127 to 582       582/582
(100 %)
0 diff
(100 %id)
BP356439 mammary gland .a 104 to 535 152 to 583       583/583
(100 %)
0 diff
(100 %id)
DB063959 testis .a 104 to 520 142 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB069825 testis .a 104 to 468 181 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB070599 testis .a 104 to 488 167 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB073011 testis .a 104 to 520 127 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB076195 testis .a 104 to 507 136 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB148356 thymus .a 104 to 515 154 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB159871 thymus .a 104 to 571 127 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
AU142692   .a 120 to 942 2 to 822   capped   821/885
(92 %)
4 diff
(99.6 %id)
DA452906 tongue, tumor tissue .a 128 to 691 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP335899 coronary artery .a 129 to 711 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP364840 lung .a 137 to 719 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP233712 coronary artery .a 144 to 729 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
DA606640   .a 145 to 653 2 to 512   capped   511/511
(100 %)
2 diff
(99.7 %id)
BQ428509 leiomyosarcoma, uterus .a 176 to 1100 1 to 925       925/925
(100 %)
4 diff
(99.6 %id)
CN336132 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 265 to 873 1 to 611       611/615
(99 %)
4 diff
(99.4 %id)
DA507847 brain .a 272 to 818 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
N85424   .a 300 to 621 1 to 316       316/316
(100 %)
15 diff
(95.3 %id)
DA489600 brain .a 314 to 868 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
EH347207   .a 329 to 415 1 to 88       88/95
(92 %)
2 diff
(97.9 %id)
DB082311 testis .a 421 to 968 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA440276 tongue, tumor tissue .a 427 to 1008 2 to 583   capped   582/583
(99 %)
1 diff
(99.9 %id)
DA496107 brain .a 430 to 990 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
AU130840   .a 470 to 1285 2 to 827   capped   826/850
(97 %)
18 diff
(97.9 %id)
DB096203 testis .a 501 to 1058 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
TI_1968234929   .a 563 to 1715 10 to 1150       1141/1302
(87 %)
20 diff
(98.5 %id)
FN170493 breast carcinoma .a 666 to 763 100 to 2     Submitted on the opposite strand 99/100
(99 %)
0 diff
(100 %id)
TI_1968234933   .a 1012 to 2073 8 to 1066       1059/1283
(82 %)
10 diff
(99.3 %id)
CN336161 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1036 to 1466 1 to 431       431/431
(100 %)
0 diff
(100 %id)
DA458738 tongue, tumor tissue .a 1094 to 1661 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
TI_1968231545   .a 1100 to 2207 1 to 1099       1102/1263
(87 %)
48 diff
(96.2 %id)
CX783557 human embryonic stem cells .a 1243 to 2042 1 to 800       800/800
(100 %)
0 diff
(100 %id)
DA937844 Spleen .a 1276 to 1833 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CN336176 embryonic stem cells, cell lines H1, H7, andH9 .a 1355 to 1813 1 to 459       459/459
(100 %)
0 diff
(100 %id)
DA644069   .a 1356 to 1932 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA718345   .a 1377 to 1967 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA903312   .a 1384 to 1858 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
BM750433 Ascites, stomach .a 1400 to 1909 1 to 510       510/510
(100 %)
0 diff
(100 %id)
DA051503   .a 1411 to 2000 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DA472302   .a 1411 to 1974 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB067858 testis .a 1412 to 1960 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA612018   .a 1415 to 1966 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BM834385 stomach .a 1415 to 2041 1 to 627       627/627
(100 %)
0 diff
(100 %id)
CN336152 embryonic stem cells, cell lines H1, H7, andH9 .a 1432 to 1874 1 to 443       443/443
(100 %)
0 diff
(100 %id)
TI_1968231547   .a 1477 to 2643 1 to 1153       1153/1241
(92 %)
21 diff
(98.4 %id)
TI_154168450   .a 1510 to 2102 124 to 718       595/866
(68 %)
39 diff
(95.5 %id)
BQ438926 embryonal carcinoma, cell line, testis .a 1570 to 2373 1 to 809       809/891
(90 %)
15 diff
(98.4 %id)
AU126216   .a 1607 to 2364 2 to 759   capped   758/886
(85 %)
9 diff
(99.0 %id)
BE083981 breast .a 1634 to 1873 240 to 1     Submitted on the opposite strand 240/262
(91 %)
1 diff
(99.7 %id)
AL040877 testis .a 1635 to 2259 1 to 625       625/625
(100 %)
0 diff
(100 %id)
BP253217 Kidney .a 1662 to 2243 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM749174 stomach .a 1696 to 2305 7 to 616       610/616
(99 %)
0 diff
(100 %id)
BQ946184 leiomyosarcoma, uterus .a 1771 to 2667 1 to 899       899/899
(100 %)
3 diff
(99.7 %id)
TI_154154033   .a 1785 to 2417 80 to 712       633/634
(99 %)
5 diff
(99.3 %id)
BM473617 duodenal adenocarcinoma, cell line, small intestine .a 1796 to 2811 1 to 1013       1013/1119
(90 %)
19 diff
(98.4 %id)
BU542942 carcinoma, cell line, Prostate .a 1826 to 2644 1 to 828       828/919
(90 %)
16 diff
(98.3 %id)
BM829037 Ascites, stomach .a 1829 to 2167 1 to 339       339/339
(100 %)
0 diff
(100 %id)
TI_154167730   .a 1854 to 2626 80 to 852       773/773
(100 %)
13 diff
(98.4 %id)
CN336135 embryonic stem cells, cell lines H1, H7, andH9 .a 1899 to 2611 1 to 714       714/714
(100 %)
3 diff
(99.6 %id)
DA003249   .a 1919 to 2479 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AU126317   .a 1921 to 2610 2 to 699   capped   698/699
(99 %)
14 diff
(98.0 %id)
CX788335 human embryonic stem cells .a 1928 to 2542 1 to 615       615/615
(100 %)
0 diff
(100 %id)
DB030064 testis .a 2043 to 2631 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA001571   .a 2088 to 2657 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
FN089027 breast carcinoma .a 2179 to 2228 56 to 7     Submitted on the opposite strand 50/57
(87 %)
0 diff
(100 %id)
TI_154152639   .a 2180 to 2668 569 to 81     Submitted on the opposite strand 489/510
(95 %)
13 diff
(97.5 %id)
BJ990483 hepatoblastoma .a 2203 to 2794 9 to 600       592/600
(98 %)
6 diff
(99.0 %id)
BP369589 testis .a 2207 to 2776 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BQ423569 embryonal carcinoma, cell line, testis .a 2226 to 3083 1 to 866       866/870
(99 %)
14 diff
(98.4 %id)
CN336128 embryonic stem cells, cell lines H1, H7, andH9 .a 2263 to 3018 1 to 753       753/754
(99 %)
4 diff
(99.5 %id)
BM464642 lymph, lymphoma, cell line .a 2263 to 3278 1 to 1018       1018/1056
(96 %)
9 diff
(99.2 %id)
AL559058 T cells from T cell leukemia .a 2311 to 3053 15 to 759       745/759
(98 %)
8 diff
(99.0 %id)
TI_59392154   .a 2333 to 3121 81 to 868       788/788
(100 %)
6 diff
(99.3 %id)
BG615835 embryonal carcinoma, testis .a 2334 to 3059 1 to 731       731/754
(96 %)
17 diff
(97.8 %id)
BM014172 breast, mammary adenocarcinoma, cell line .a 2334 to 3121 1 to 787       787/787
(100 %)
6 diff
(99.3 %id)
BU430909 lymph .a 2338 to 2668 338 to 8     Submitted on the opposite strand 331/338
(97 %)
0 diff
(100 %id)
BU618677 Cell Line, Chondrosarcoma .a 2351 to 3024 689 to 16   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 674/689
(97 %)
0 diff
(100 %id)
DA502508 brain .a 2384 to 2935 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_154167148   .a 2410 to 2889 59 to 538       480/543
(88 %)
11 diff
(98.0 %id)
BG777023 lung, mucoepidermoid carcinoma .a 2415 to 3084 40 to 710       671/720
(93 %)
11 diff
(98.5 %id)
TI_154160431   .a 2460 to 3009 84 to 633       550/550
(100 %)
0 diff
(100 %id)
BM710690 eye, fetal eyes .a 2462 to 2636 1 to 175       175/175
(100 %)
0 diff
(100 %id)
CN336175 embryonic stem cells, cell lines H1, H7, andH9 .a 2516 to 3084 1 to 569       569/576
(98 %)
2 diff
(99.7 %id)
DB089988 testis .a 2519 to 3081 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BG110847 Bone, osteosarcoma, cell line .a 2530 to 3267 1 to 737       737/788
(93 %)
7 diff
(99.2 %id)
BP243399 Liver .a 2589 to 3164 1 to 576       576/576
(100 %)
0 diff
(100 %id)
TI_1968234321   .a 2602 to 3737 1138 to 13       1126/1297
(86 %)
11 diff
(99.2 %id)
BQ946025 leiomyosarcoma, uterus .a 2641 to 3570 1 to 932       932/932
(100 %)
9 diff
(99.1 %id)
BQ431413 eye, retinoblastoma .a 2673 to 3369 1 to 695       695/909
(76 %)
6 diff
(99.4 %id)
TI_57186730   .a 2680 to 3398 32 to 750       719/750
(95 %)
6 diff
(99.2 %id)
BF968100 adrenal cortex carcinoma, cell line, adrenal gland .a 2699 to 3532 1 to 833       833/971
(85 %)
32 diff
(96.8 %id)
AK024080 whole embryo, mainly head .a 2725 to 3937 1 to 1213   available from FLJ,   1213/1213
(100 %)
0 diff
(100 %id)
AU117343 whole embryo, mainly head .a 2726 to 3497 2 to 776   fully sequenced, capped   775/775
(100 %)
1 diff
(99.9 %id)
CN336136 embryonic stem cells, DMSO-treated H9 cellline .a 2774 to 2977 1 to 204       204/204
(100 %)
0 diff
(100 %id)
GW493074 diffuse (Lauren) gastric adenocarcinoma, stomach .a 2774 to 3185 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
DB131970 thymus .a 2801 to 3347 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
TI_1968234931   .a 2825 to 3927 1110 to 10       1139/1290
(88 %)
18 diff
(98.7 %id)
CN336155 embryonic stem cells, cell lines H1, H7, andH9 .a 2846 to 3569 1 to 724       724/724
(100 %)
0 diff
(100 %id)
BI260210 cervical carcinoma cell line, cervix .a 2848 to 3505 126 to 785       660/924
(71 %)
14 diff
(98.5 %id)
BU507523 leiomyosarcoma, uterus .a 2854 to 3617 1 to 767       767/855
(89 %)
4 diff
(99.6 %id)
CN336143 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2858 to 3484 1 to 627       627/627
(100 %)
0 diff
(100 %id)
CF785876 mixed .a 2863 to 3565 12 to 715       704/842
(83 %)
13 diff
(98.5 %id)
TI_154126366   .a 2883 to 3801 978 to 64   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 915/1071
(85 %)
25 diff
(97.7 %id)
CB160390 Liver .a 2888 to 3431 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
CN336167 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2910 to 3518 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BX348550   .a 2911 to 3717 15 to 832       815/920
(88 %)
25 diff
(97.3 %id)
AL597625   .a 2915 to 3448 1 to 534       534/534
(100 %)
0 diff
(100 %id)
CB218533 mandible, pooled .a 2945 to 3344 24 to 425     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 402/425
(94 %)
13 diff
(97.0 %id)
AI471482 follicular lymphoma, lymph node .a 2954 to 3493 539 to 1       539/539
(100 %)
3 diff
(99.5 %id)
BM561210 duodenal adenocarcinoma, cell line, small intestine .a 2959 to 3802 1 to 849       849/952
(89 %)
21 diff
(97.8 %id)
CB218365 mandible, pooled .a 2960 to 3522 1 to 563   AAA   563/563
(100 %)
1 diff
(99.9 %id)
CB218779 mandible, pooled .a 2960 to 3524 1 to 563     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 563/567
(99 %)
10 diff
(98.3 %id)
CN336131 embryonic stem cells, DMSO-treated H9 cellline .a 2978 to 3439 1 to 462       462/519
(89 %)
3 diff
(99.5 %id)
BM823856 Ascites, stomach .a 2984 to 3474 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
BQ049105 lymph, lymphoma, cell line .a 2989 to 3803 1 to 815       815/1005
(81 %)
10 diff
(99.1 %id)
BQ049288 lymph, lymphoma, cell line .a 2989 to 3896 1 to 912       912/1008
(90 %)
13 diff
(98.8 %id)
TI_1968231553   .a 3007 to 4137 26 to 1162       1137/1306
(87 %)
10 diff
(99.3 %id)
AI827444 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3022 to 3776 752 to 1       752/752
(100 %)
10 diff
(98.7 %id)
AW003286 pooled germ cell tumors .a 3047 to 3806 768 to 10   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 759/773
(98 %)
56 diff
(92.8 %id)
BF223254 pooled germ cell tumors .a 3056 to 3776 721 to 1       721/721
(100 %)
2 diff
(99.8 %id)
EH341030   .a 3069 to 3144 1 to 76       76/76
(100 %)
0 diff
(100 %id)
BM147992 leukopheresis .a 3073 to 3497 1 to 424       424/474
(89 %)
50 diff
(89.5 %id)
DA643866   .a 3090 to 3675 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA737413   .a 3090 to 3522 2 to 434   fully sequenced, capped   433/433
(100 %)
0 diff
(100 %id)
DN601760 human embryonic stem cells .a 3126 to 3827 1 to 702       702/702
(100 %)
0 diff
(100 %id)
CX166084 human embryonic stem cells differentiated toan early endodermal cell type .a 3132 to 3859 1 to 728       728/728
(100 %)
0 diff
(100 %id)
AI765634 2 pooled tumors (clear cell type), Kidney .a 3146 to 3779 631 to 1       631/631
(100 %)
4 diff
(99.4 %id)
CN336147 embryonic stem cells, DMSO-treated H9 cellline .a 3153 to 3723 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
AI742333 pooled .a 3154 to 3779 626 to 1       626/634
(98 %)
2 diff
(99.7 %id)
BQ775554 Bone, Human Chondrosarcoma Cell Line .a 3154 to 3792 641 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 639/641
(99 %)
1 diff
(99.9 %id)
CN336170 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3160 to 3695 539 to 4   AAA Submitted on the opposite strand 536/539
(99 %)
6 diff
(98.9 %id)
AI948838 pooled germ cell tumors .a 3166 to 3773 611 to 3       609/618
(98 %)
6 diff
(99.1 %id)
BM559052 eye, retinoblastoma .a 3170 to 4170 1 to 1019       1017/1026
(99 %)
24 diff
(97.7 %id)
AW172827 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3174 to 3802 629 to 1       629/629
(100 %)
0 diff
(100 %id)
TI_149280081   .a 3180 to 3793 673 to 60       614/782
(78 %)
0 diff
(100 %id)
BU679027 lung, Primary Lung Epithelial Cells .a 3180 to 3792 613 to 1       613/621
(98 %)
3 diff
(99.6 %id)
BU608401 Human Lung Epithelial cells, lung .a 3180 to 3792 613 to 1       613/622
(98 %)
4 diff
(99.4 %id)
CB409836 maxilla, pooled .a 3181 to 3791 631 to 21   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 611/631
(96 %)
0 diff
(100 %id)
BE046383 colon, juvenile granulosa tumor .a 3190 to 3776 587 to 1       587/587
(100 %)
6 diff
(99.0 %id)
AU159942   .a 3200 to 3774 567 to 1       567/567
(100 %)
13 diff
(97.8 %id)
AI734240.
matches multiple genes
lung .a 3207 to 3800 1 to 593     also hits gene ALKBH1 593/601
(98 %)
2 diff
(99.7 %id)
W16699.
matches multiple genes
lung .a 3207 to 3721 1 to 508     also hits gene ALKBH1 508/508
(100 %)
9 diff
(98.3 %id)
AU152724   .a 3230 to 3774 549 to 1       549/551
(99 %)
9 diff
(98.4 %id)
CB158932 Liver .a 3237 to 3767 1 to 531       531/531
(100 %)
0 diff
(100 %id)
DB370009   .a 3248 to 3522 275 to 1   fully sequenced,   275/275
(100 %)
0 diff
(100 %id)
AI289433 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3252 to 3780 533 to 5       529/533
(99 %)
4 diff
(99.3 %id)
BU849263 mixed (pool of 40 RNAs) .a 3272 to 3903 1 to 629       629/880
(71 %)
25 diff
(97.2 %id)
BM834136 stomach .a 3275 to 3845 1 to 571       571/571
(100 %)
0 diff
(100 %id)
TI_1968234355   .a 3279 to 4409 1136 to 15       1122/1297
(86 %)
13 diff
(99.0 %id)
BG261340 bladder, transitional cell papilloma, cell line .a 3290 to 3792 1 to 503   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 503/505
(99 %)
4 diff
(99.3 %id)
AI990075 pooled germ cell tumors .a 3306 to 3774 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AU185705 skin .a 3339 to 3524 186 to 1       186/186
(100 %)
0 diff
(100 %id)
TI_57228496   .a 3341 to 4169 54 to 891       838/838
(100 %)
17 diff
(98.0 %id)
FN062379 breast carcinoma .a 3353 to 3467 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
AA129533 lung, lung carcinoma .a 3369 to 3782 421 to 1     Submitted on the opposite strand 421/441
(95 %)
17 diff
(96.2 %id)
TI_1968236093   .a 3371 to 4322 955 to 6       950/1232
(77 %)
16 diff
(98.8 %id)
FN118099 breast carcinoma .a 3376 to 3486 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
BM832666 stomach .a 3385 to 3846 1 to 462       462/462
(100 %)
0 diff
(100 %id)
AI760467 colon, colon tumor, RER+ .a 3393 to 3780 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AA678935   .a 3415 to 3689 276 to 1       276/276
(100 %)
30 diff
(89.2 %id)
TI_1968236397   .a 3442 to 4390 953 to 7       949/1304
(72 %)
18 diff
(98.7 %id)
AU144199 whole embryo, mainly head .a 3467 to 3937 466 to 1   fully sequenced,   466/466
(100 %)
1 diff
(99.8 %id)
AI186928 lung .a 3484 to 3776 293 to 1       293/293
(100 %)
0 diff
(100 %id)
DA888910   .a 3495 to 4054 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AI127486 heart .a 3500 to 3774 275 to 1       275/275
(100 %)
0 diff
(100 %id)
BF830671 head_neck .a 3504 to 4035 532 to 3     Submitted on the opposite strand 530/532
(99 %)
9 diff
(98.4 %id)
CN336166 embryonic stem cells, DMSO-treated H9 cellline .a 3508 to 4236 1 to 728       728/728
(100 %)
1 diff
(99.9 %id)
CN336184 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3544 to 4101 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DB128723 thymus .a 3560 to 4129 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
FN148902 breast carcinoma .a 3574 to 3697 1 to 124       124/126
(98 %)
5 diff
(96.1 %id)
AA310903   .a 3608 to 3899 1 to 292       292/292
(100 %)
0 diff
(100 %id)
AW137854   .a 3612 to 3884 275 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 272/275
(98 %)
0 diff
(100 %id)
BQ304766 breast .a 3639 to 3855 1 to 218       218/227
(96 %)
12 diff
(94.8 %id)
BM750820 Ascites, stomach .a 3651 to 4212 1 to 562       562/562
(100 %)
0 diff
(100 %id)
TI_1968231549   .a 3655 to 4891 1 to 1211       1211/1269
(95 %)
41 diff
(96.8 %id)
DW424064 Liver .a 3665 to 3894 10 to 239   AAA   230/248
(92 %)
7 diff
(97.2 %id)
AL601658   .a 3674 to 4127 1 to 454       454/454
(100 %)
0 diff
(100 %id)
AA306035   .a 3699 to 4113 1 to 415       415/415
(100 %)
0 diff
(100 %id)
CN336160 embryonic stem cells, DMSO-treated H9 cellline .a 3706 to 4393 1 to 688       688/688
(100 %)
0 diff
(100 %id)
BF795918 lymph, lymphoma, cell line .a 3708 to 4508 1 to 787       787/988
(79 %)
25 diff
(97.5 %id)
CN336137 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3735 to 4460 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
CB159159 Liver .a 3746 to 4331 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DB050734 testis .a 3800 to 4343 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
BM468714 leiomyosarcoma, uterus .a 3814 to 4779 1 to 966       966/966
(100 %)
37 diff
(96.2 %id)
TI_59392500   .a 3818 to 4646 47 to 877       831/832
(99 %)
7 diff
(99.2 %id)
BM014473 breast, mammary adenocarcinoma, cell line .a 3819 to 4646 1 to 830       830/831
(99 %)
7 diff
(99.2 %id)
BM804164 eye, retinoblastoma .a 3826 to 4795 1 to 983       983/1112
(88 %)
23 diff
(98.0 %id)
AA306247   .a 3840 to 4256 1 to 417       417/417
(100 %)
0 diff
(100 %id)
DB014659 esophageal, tumor tissue .a 3846 to 4420 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BQ221137 melanotic melanoma, skin .a 3872 to 4780 1 to 916       916/918
(99 %)
16 diff
(98.3 %id)
BG681127 skin, squamous cell carcinoma .a 3908 to 4832 1 to 925       925/952
(97 %)
23 diff
(97.6 %id)
BG287692 bladder, transitional cell papilloma, cell line .a 3911 to 4613 710 to 11     Submitted on the opposite strand 700/1042
(67 %)
14 diff
(98.7 %id)
BU520840 leiomyosarcoma, uterus .a 3938 to 4800 1 to 866       866/867
(99 %)
5 diff
(99.5 %id)
CN336165 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3979 to 4592 1 to 614       614/614
(100 %)
0 diff
(100 %id)
AL524953 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 4002 to 4678 1 to 679       679/679
(100 %)
2 diff
(99.8 %id)
TI_154140374   .a 4019 to 4739 86 to 806       721/723
(99 %)
15 diff
(98.0 %id)
BU164121 large cell carcinoma, lung .a 4020 to 4887 1 to 885       885/899
(98 %)
20 diff
(97.8 %id)
CX783225 human embryonic stem cells .a 4048 to 4838 1 to 790       790/790
(100 %)
2 diff
(99.8 %id)
CN336180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4068 to 4698 1 to 631       631/631
(100 %)
0 diff
(100 %id)
CB158973 Liver .a 4132 to 4720 1 to 589       589/589
(100 %)
0 diff
(100 %id)
TI_57231007   .a 4149 to 4726 92 to 669       578/580
(99 %)
1 diff
(99.9 %id)
CN336169 embryonic stem cells, DMSO-treated H9 cellline .a 4184 to 4781 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM802577 embryonal carcinoma, cell line, testis .a 4201 to 5070 1 to 876       876/1134
(77 %)
19 diff
(98.4 %id)
CX872099 embryonic stem .a 4217 to 5033 1 to 817       817/817
(100 %)
0 diff
(100 %id)
TI_154139371   .a 4229 to 4876 78 to 724       647/648
(99 %)
14 diff
(97.9 %id)
TI_154139136   .a 4250 to 4880 80 to 710       631/631
(100 %)
2 diff
(99.7 %id)
TI_154139644   .a 4262 to 4874 80 to 696       617/849
(72 %)
54 diff
(93.7 %id)
CB140758 Liver .a 4281 to 4764 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BQ425528 eye, retinoblastoma .a 4291 to 5170 1 to 880       880/880
(100 %)
5 diff
(99.5 %id)
CR625760 Neuroblastoma Cot 10-normalized .a 4315 to 5656 1 to 1342       1342/1342
(100 %)
0 diff
(100 %id)
AL519920 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 4315 to 5281 1 to 965   fully sequenced,   965/965
(100 %)
0 diff
(100 %id)
CX871960 embryonic stem .a 4315 to 5071 1 to 758       758/758
(100 %)
1 diff
(99.9 %id)
DR759727 embryonic stem .a 4329 to 5104 1 to 776       776/776
(100 %)
0 diff
(100 %id)
CX869237 embryonic stem .a 4380 to 5176 1 to 797   fully sequenced,   797/797
(100 %)
0 diff
(100 %id)
CX872907 embryonic stem .a 4398 to 5248 1 to 851       851/851
(100 %)
0 diff
(100 %id)
BI858861 breast, mammary adenocarcinoma, cell line .a 4406 to 5195 1 to 791       791/791
(100 %)
8 diff
(99.0 %id)
TI_57191269   .a 4406 to 5195 56 to 846       791/791
(100 %)
8 diff
(99.0 %id)
CN336162 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4469 to 5226 1 to 758       758/758
(100 %)
2 diff
(99.8 %id)
CN336146 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4478 to 4934 1 to 457       457/457
(100 %)
0 diff
(100 %id)
BM698924 eye, fetal eyes .a 4510 to 5091 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CB115803 Liver .a 4519 to 5075 1 to 557       557/557
(100 %)
0 diff
(100 %id)
TI_1968231551   .a 4551 to 5446 18 to 910       893/1249
(71 %)
4 diff
(99.7 %id)
CN336133 embryonic stem cells, DMSO-treated H9 cellline .a 4559 to 5251 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
CA488771   .a 4569 to 5307 1 to 743       743/910
(81 %)
9 diff
(99.1 %id)
FN161342 breast carcinoma .a 4570 to 4670 101 to 1     Submitted on the opposite strand 101/101
(100 %)
0 diff
(100 %id)
BM763329 myeloma .a 4581 to 5249 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
T29025 blood, white blood cells .a 4585 to 4881 1 to 297       297/297
(100 %)
0 diff
(100 %id)
FN128435 breast carcinoma .a 4605 to 4683 93 to 14     Submitted on the opposite strand 80/94
(85 %)
0 diff
(100 %id)
CN336183 embryonic stem cells, DMSO-treated H9 cellline .a 4658 to 5349 1 to 692       692/692
(100 %)
0 diff
(100 %id)
CN336172 embryonic stem cells, DMSO-treated H9 cellline .a 4661 to 5324 1 to 664       664/664
(100 %)
0 diff
(100 %id)
CB146750 Liver .a 4670 to 5296 1 to 627       627/627
(100 %)
0 diff
(100 %id)
L47276   .a 4676 to 5670 1 to 995       995/995
(100 %)
1 diff
(99.9 %id)
L47277   .a 4676 to 5669 1 to 994   tiling clone,   994/994
(100 %)
0 diff
(100 %id)
TI_154098092   .a 4749 to 5670 1004 to 93   AAA   912/1153
(79 %)
31 diff
(97.4 %id)
FN060090 breast carcinoma .a 4753 to 4869 1 to 117       117/117
(100 %)
1 diff
(99.2 %id)
TI_154030183   .a 4772 to 5681 915 to 24       892/991
(90 %)
29 diff
(97.1 %id)
TI_154124820   .a 4838 to 5670 900 to 79   AAA   822/971
(84 %)
10 diff
(99.0 %id)
BG168017 hypernephroma, cell line, Kidney .a 4856 to 5461 1 to 606       606/607
(99 %)
1 diff
(99.9 %id)
AL580759 T cells from T cell leukemia .a 4903 to 5610 719 to 1       719/720
(99 %)
17 diff
(97.7 %id)
TI_149293432   .a 4912 to 5670 816 to 64   AAA   753/950
(79 %)
7 diff
(99.3 %id)
TI_154123752   .a 4912 to 5670 830 to 86   AAA   745/957
(77 %)
29 diff
(97.0 %id)
AL524952 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 4941 to 5632 692 to 1       692/692
(100 %)
4 diff
(99.5 %id)
TI_149286144   .a 4970 to 5670 790 to 91   AAA   700/701
(99 %)
8 diff
(98.9 %id)
CA415885 Chondrosarcoma Cell line .a 4970 to 5670 718 to 19   AAA   700/700
(100 %)
1 diff
(99.9 %id)
FN074591 breast carcinoma .a 4978 to 5038 1 to 61       61/62
(98 %)
1 diff
(98.4 %id)
AA568223 colon, colon tumor RER+ .a 5005 to 5495 1 to 491     Submitted on the opposite strand 491/491
(100 %)
0 diff
(100 %id)
CN336153 embryonic stem cells, cell lines H1, H7, andH9 .a 5051 to 5670 666 to 47   AAA Submitted on the opposite strand 620/620
(100 %)
2 diff
(99.7 %id)
CA424120 cell lines, Chondrosarcoma .a 5072 to 5670 617 to 19   AAA   599/599
(100 %)
0 diff
(100 %id)
BM669710 eye, fetal eyes .a 5097 to 5670 592 to 19   AAA   574/574
(100 %)
1 diff
(99.9 %id)
BX099176 placenta .a 5099 to 5670 1 to 572   AAA   572/572
(100 %)
0 diff
(100 %id)
N57027 placenta .a 5099 to 5284 1 to 186   fully sequenced,   186/186
(100 %)
0 diff
(100 %id)
BJ990484 hepatoblastoma .a 5109 to 5648 540 to 1       540/540
(100 %)
0 diff
(100 %id)
TI_154132589   .a 5113 to 5665 653 to 99   AAA   555/1024
(54 %)
11 diff
(99.0 %id)
FN107172 breast carcinoma .a 5123 to 5223 98 to 1     Submitted on the opposite strand 98/98
(100 %)
3 diff
(97.0 %id)
FN139699 breast carcinoma .a 5129 to 5199 1 to 71       71/77
(92 %)
3 diff
(96.2 %id)
BQ012547 placenta .a 5132 to 5670 557 to 19   AAA   539/539
(100 %)
0 diff
(100 %id)
BI048308 stomach .a 5133 to 5373 245 to 2       244/249
(97 %)
0 diff
(100 %id)
FN168937 breast carcinoma .a 5136 to 5233 96 to 1     Submitted on the opposite strand 96/96
(100 %)
2 diff
(98.0 %id)
CX869159 embryonic stem .a 5146 to 5670 551 to 27   fully sequenced, AAA   525/525
(100 %)
0 diff
(100 %id)
FN141084 breast carcinoma .a 5148 to 5244 94 to 1     Submitted on the opposite strand 94/94
(100 %)
3 diff
(96.9 %id)
AW263710 lung, two pooled squamous cell carcinomas .a 5154 to 5671 518 to 1       518/518
(100 %)
0 diff
(100 %id)
BM145215 leukopheresis .a 5159 to 5681 528 to 6       523/529
(98 %)
8 diff
(98.5 %id)
CB119559 Liver .a 5172 to 5659 488 to 1     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
AA583483 germ cell tumor .a 5181 to 5675 495 to 1       495/495
(100 %)
0 diff
(100 %id)
DN914357   .a 5185 to 5677 493 to 1   tiling clone,   493/493
(100 %)
3 diff
(99.4 %id)
BQ008257 Chondrosarcoma, Left Pelvis .a 5192 to 5670 497 to 19   AAA   479/479
(100 %)
0 diff
(100 %id)
BQ015669 placenta .a 5198 to 5670 490 to 18   AAA   473/473
(100 %)
0 diff
(100 %id)
AI887722 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 5206 to 5675 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AW074313 2 pooled high-grade transitional celltumors, genitourinary tract .a 5206 to 5671 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AI123885 heart .a 5208 to 5670 463 to 1       463/463
(100 %)
0 diff
(100 %id)
AA236763 germinal center B cell .a 5212 to 5643 1 to 432       432/432
(100 %)
0 diff
(100 %id)
AI354911 lung .a 5216 to 5670 455 to 1       455/462
(98 %)
0 diff
(100 %id)
FN102315 breast carcinoma .a 5220 to 5318 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
AA236734 germinal center B cell .a 5239 to 5670 1 to 432   fully sequenced,   432/432
(100 %)
0 diff
(100 %id)
AL561834 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 5251 to 5656 407 to 1   fully sequenced,   407/407
(100 %)
1 diff
(99.8 %id)
FN080092 breast carcinoma .a 5251 to 5356 1 to 107       107/107
(100 %)
3 diff
(97.2 %id)
AI446783 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 5252 to 5672 421 to 1       421/421
(100 %)
0 diff
(100 %id)
DN918090   .a 5253 to 5672 421 to 2       420/421
(99 %)
0 diff
(100 %id)
N29334 placenta .a 5254 to 5670 418 to 1   fully sequenced,   418/418
(100 %)
1 diff
(99.8 %id)
AI613495 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5255 to 5670 426 to 11   AAA   416/416
(100 %)
0 diff
(100 %id)
AA702453 liver and spleen .a 5262 to 5670 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AA806022 germinal center B cell .a 5292 to 5670 389 to 11   AAA   379/379
(100 %)
0 diff
(100 %id)
AA809450 germinal center B cell .a 5314 to 5670 370 to 14   AAA   357/357
(100 %)
0 diff
(100 %id)
AA768810 germinal center B cell .a 5319 to 5670 362 to 11   AAA   352/352
(100 %)
0 diff
(100 %id)
AA729280 alveolar rhabdomyosarcoma .a 5326 to 5672 350 to 5       346/353
(98 %)
0 diff
(100 %id)
AA806238 germinal center B cell .a 5331 to 5670 350 to 11   AAA   340/340
(100 %)
0 diff
(100 %id)
BE045915 pooled germ cell tumors .a 5367 to 5670 304 to 1       304/304
(100 %)
0 diff
(100 %id)
BG107444 Bone, osteosarcoma, cell line .a 5370 to 5670 1 to 301   AAA   301/301
(100 %)
0 diff
(100 %id)
AA731314 germinal center B cell .a 5380 to 5670 317 to 27   AAA   291/291
(100 %)
0 diff
(100 %id)
AA649568 alveolar rhabdomyosarcoma .a 5388 to 5676 292 to 4       289/298
(96 %)
0 diff
(100 %id)
BU186513 embryonal carcinoma, cell line, testis .a 5390 to 5669 1 to 280   AAA   280/280
(100 %)
0 diff
(100 %id)
AW063876 thymus .a 5400 to 5669 269 to 1     Submitted on the opposite strand 269/269
(100 %)
4 diff
(98.6 %id)
BU517162 leiomyosarcoma, uterus .a 5409 to 5670 1 to 262   AAA   262/262
(100 %)
0 diff
(100 %id)
FN125278 breast carcinoma .a 5412 to 5506 96 to 2     Submitted on the opposite strand 95/96
(98 %)
0 diff
(100 %id)
FN129350 breast carcinoma .a 5422 to 5517 92 to 1     Submitted on the opposite strand 92/94
(97 %)
3 diff
(96.9 %id)
AA236910 germinal center B cell .a 5438 to 5670 233 to 1   fully sequenced,   233/233
(100 %)
0 diff
(100 %id)
FN047994 breast carcinoma .a 5444 to 5549 105 to 1     Submitted on the opposite strand 105/105
(100 %)
1 diff
(99.1 %id)
BY999554   .a 5448 to 5634 1 to 187     Submitted on the opposite strand 187/188
(99 %)
1 diff
(99.5 %id)
GD149625   .a 5479 to 5681 7 to 209       203/214
(94 %)
6 diff
(97.2 %id)
AW821790 stomach .a 5480 to 5625 154 to 8       147/168
(87 %)
0 diff
(100 %id)
BE150864 head_neck .a 5480 to 5673 207 to 15     Submitted on the opposite strand 193/221
(87 %)
0 diff
(100 %id)
BE937589 stomach .a 5480 to 5625 154 to 8       147/168
(87 %)
0 diff
(100 %id)
GD158371   .a 5482 to 5669 9 to 196   AAA   188/196
(95 %)
6 diff
(97.0 %id)
AA550969 adrenal adenoma, adrenal gland .a 5506 to 5675 180 to 11   AAA   170/170
(100 %)
0 diff
(100 %id)
EH341840   .a 5557 to 5638 1 to 82       82/82
(100 %)
0 diff
(100 %id)
AF285157   .b 1 to 1569 6 to 1578 N419I L420F L421S V422F F423S ... tiling clone,   1578/1578
(100 %)
4 diff
(99.8 %id)
DB061604 testis .c 1 to 578 2 to 579 exact tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
BY996157   .d 1 to 657 12 to 669 exact tiling clone,   658/669
(98 %)
6 diff
(99.2 %id)
AA010056 liver and spleen .e 1 to 344 1 to 347   tiling clone,   347/347
(100 %)
4 diff
(98.9 %id)
BX101712 liver and spleen .e 98 to 598 1 to 508   tiling clone,   508/508
(100 %)
4 diff
(99.3 %id)
T84236 liver and spleen .e 98 to 358 1 to 261       261/261
(100 %)
2 diff
(99.3 %id)
R00631 liver and spleen .e 98 to 343 1 to 247       247/247
(100 %)
3 diff
(98.8 %id)
T96522 liver and spleen .e 99 to 448 1 to 359   fully sequenced,   359/359
(100 %)
8 diff
(97.8 %id)
H64302 liver and spleen .e 140 to 418 1 to 280   fully sequenced,   280/280
(100 %)
5 diff
(98.3 %id)
AA766848 germinal center B cell .e 223 to 425 205 to 3       203/205
(99 %)
0 diff
(100 %id)
AI076105 liver and spleen .e 306 to 712 423 to 9   tiling clone,   415/423
(98 %)
0 diff
(100 %id)
T88713 liver and spleen .e 374 to 715 360 to 1       360/379
(94 %)
6 diff
(98.5 %id)
H64303 liver and spleen .e 388 to 721 342 to 1   fully sequenced,   342/342
(100 %)
5 diff
(98.6 %id)
R00530 liver and spleen .e 414 to 716 312 to 1       312/347
(89 %)
6 diff
(98.3 %id)
T96523 liver and spleen .e 418 to 721 312 to 1   tiling clone, fully sequenced,   312/312
(100 %)
5 diff
(98.4 %id)
DA944183 Spleen .e 600 to 1152 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BP331463 rectum .f-u 1 to 502 1 to 501   tiling clone,   501/517
(96 %)
4 diff
(99.3 %id)
CN274456 embryonic stem cells, DMSO-treated H9 cellline .f-u 427 to 787 1 to 361   tiling clone,   361/361
(100 %)
1 diff
(99.8 %id)
N79502.
matches multiple genes
lung .g 1 to 423 425 to 1 K8T V10X tiling clone, also hits gene WDR75 425/426
(99 %)
3 diff
(99.3 %id)
N79503.
matches multiple genes
lung .g 5 to 424 420 to 1   tiling clone, also hits gene MOV10 420/420
(100 %)
0 diff
(100 %id)
BG952452 colon .h-u 1 to 319 7 to 322 F17L tiling clone,   316/322
(98 %)
6 diff
(98.2 %id)
AF285158   Gene TOP2A, variant not shown         This clone was ignored    
AW970457   Gene TOP2A, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI